Copyright
©The Author(s) 2024.
World J Gastroenterol. Jan 14, 2024; 30(2): 128-136
Published online Jan 14, 2024. doi: 10.3748/wjg.v30.i2.128
Published online Jan 14, 2024. doi: 10.3748/wjg.v30.i2.128
What is currently known | Remaining knowledge gaps |
Pathophysiological mechanisms behind the onset and progression of HRS[1-5] | Exact timing and sequelae of cirrhotic cardiomyopathy in the setting of HRS[10-25] |
Targeted prevention and interventional strategies to prevent the onset and terminate the progression of HRS[1-5] | Potential pathophysiological mechanisms that interlink the onset and progression of cardiac dysfunction in HRS[11,18,23,27-34,37] |
Optimal screening markers and imaging modalities in the clinical setting to diagnose cardiac disease in cirrhosis and HRS, and to prognosticate outcomes[9,38-47] | |
How can specific interventions like volume expansion using albumin and TIPS improve HRS-associated cardiac dysfunctions?[31,48-58] |
- Citation: Wu HHL, Rakisheva A, Ponnusamy A, Chinnadurai R. Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity? World J Gastroenterol 2024; 30(2): 128-136
- URL: https://www.wjgnet.com/1007-9327/full/v30/i2/128.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i2.128